Current Enterprise Value (EV)
Current share price (P) | $110.03 |
No. shares of common stock outstanding | 1,246,265,857 |
US$ in millions | |
Common equity (market value)1 | 137,127) |
Add: Preferred stock, par value $0.001 per share; none outstanding (per books) | —) |
Add: Noncontrolling interest (per books) | (84) |
Total equity | 137,043) |
Add: Current portion of long-term debt and other obligations, net (per books) | 1,798) |
Add: Long-term debt, net, excluding current portion (per books) | 23,189) |
Total equity and debt | 162,030) |
Less: Cash and cash equivalents | 6,085) |
Less: Short-term marketable debt securities | 1,179) |
Enterprise value (EV) | 154,766) |
Based on: 10-K (reporting date: 2023-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 110.03 × 1,246,265,857
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Gilead Sciences Inc. Annual Report.
3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 73.55 × 1,245,774,616
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Gilead Sciences Inc. EV increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level. |